Kos, F. T. Et Al. 2011. Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer. Chemotherapy , vol.57, no.3 , 230-235.

Kos, F. T., Uncu, D., Özdemir, N., Budakoglu, B., Odabaş, H., Abali, H., ... Oksuzoglu, B.(2011). Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer. Chemotherapy , vol.57, no.3, 230-235.

Kos, F. Et Al. "Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer," Chemotherapy , vol.57, no.3, 230-235, 2011

Kos, F. T. Et Al. "Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer." Chemotherapy , vol.57, no.3, pp.230-235, 2011

Kos, F. T. Et Al. (2011) . "Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer." Chemotherapy , vol.57, no.3, pp.230-235.

@article{article, author={F. Tugba Kos Et Al. }, title={Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer}, journal={Chemotherapy}, year=2011, pages={230-235} }